SCHEMBL4895709

SCHEMBL4895709

CCN(c1csc(-c2ccc(C(F)(F)F)cc2)n1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.40
EIF4E P06730 3/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TRPM8 Q7Z2W7 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
KDM4E B2RXH2 3/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
ACLY P53396 1/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895921 0.92 LMNA (0.40) TP53LMNAPOLBKMT2ATRPM8
SCHEMBL4902609 0.90 TP53 (0.43) TP53LMNAPOLBMEN1KMT2A
SCHEMBL4899849 0.90 LMNA (0.46) TP53LMNAPOLBEIF4EMEN1
SCHEMBL4906638 0.89 ALDH1A1 (0.44) TP53LMNAPOLBEIF4EMEN1
SCHEMBL4904200 0.88 TRPM8 (0.46) EIF4ETRPM8
SCHEMBL4906585 0.88 LMNA (0.43) TP53LMNAEIF4EMEN1KMT2A
SCHEMBL4905594 0.84 TRPM8 (0.42) LMNAMEN1KMT2ATRPM8ALDH1A1
SCHEMBL4903288 0.84 LMNA (0.47) LMNAEIF4EALDH1A1HPGDALOX15
SCHEMBL4906508 0.83 LMNA (0.41) LMNAMEN1KMT2ATRPM8ALDH1A1
SCHEMBL4903714 0.82 LMNA (0.56) LMNAPOLBMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TP53 3421/4885LMNA 319/4885POLB 1807/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TP53 3421/4885LMNA 319/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.